Sunday, September 24, 2017
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Thumbs Up/Down
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Allergan caps a bad day with news the FDA has kicked back a supplemental application for cariprazine

by John Carrollenvelope — on September 22, 2017 05:11 PM EDT
Updated: 05:15 PM

FDA spurns J&J’s troubled rheumatoid arthritis drug sirukumab

by John Carrollenvelope — on September 22, 2017 04:31 PM EDT
Updated: 05:16 PM

How Enterprise customers can get Endpoints News into their Slack

by Igor Yavychenvelope — on September 22, 2017 10:40 AM EDT

GSK vets Witty and Slaoui find new roles in biotech as the great migration continues

by Shehla Shakoorenvelope — on September 22, 2017 10:08 AM EDT
Updated: 10:10 AM

UPDATED: Two years on, Allergan’s $1.7B NASH drug still looks weak — at best

by John Carrollenvelope — on September 22, 2017 09:58 AM EDT
Updated: 11:22 AM

OrbiMed, RA Capital back a $26M raise for Realm’s two mid-stage drugs

by John Carrollenvelope — on September 22, 2017 08:34 AM EDT

AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs

by John Carrollenvelope — on September 22, 2017 07:48 AM EDT

UPDATED: House committee wants to know a lot more about the cyberattack that damaged Merck

by Arsalan Arifenvelope — on September 22, 2017 06:45 AM EDT
Updated: 09:36 AM

Versartis shares hammered by a PhIII flop as growth hormone flunks key test

by John Carrollenvelope — on September 21, 2017 04:47 PM EDT
Updated: 05:03 PM

Sanofi, NIH create a three-pronged antibody to target HIV; Akari soars on PhIII plans; Juno plots planned $225M raise

by Shehla Shakoorenvelope — on September 21, 2017 09:32 AM EDT
Updated: 09:51 AM

  • 1
  • 2
  • 3
  • 190

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • About
  • Privacy Policy
  • Media Kit

copyright 2017 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.